Adapalene [USAN:INN:BAN] | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Adapalene [USAN:INN:BAN]
US Patents

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

pharmacompass-1-m-2026-01-12

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

Contact Supplier

Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

Contact Supplier

pharmacompass-2-2026-02-09

Adapalene [USAN:INN:BAN]

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 10 USDMF, 5 CEP/COS, 5 JDMF, 4 EU WC, 6 KDMF, 11 NDC API, 26 Listed Suppliers, $ API Reference Price

45 API Suppliers
10 USDMF
5 CEP/COS
5 JDMF
4 EU WC
6 KDMF
11 NDC API
26 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

46 Drugs in Development

46 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

143 FDF Dossiers, 28 FDA Orange Book, 82 Europe, 10 Canada, 3 Australia, 8 South Africa, 12 Listed Dossiers

143 FDF Dossiers
28 FDA Orange Book
82 Europe
10 Canada
3 Australia
8 South Africa
12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

GEL;TOPICAL - 0.1%, GEL;TOPICAL - 0.3%, LOTION;TOPICAL - 0.1%

GEL;TOPICAL - 0.1%
GEL;TOPICAL - 0.3%
LOTION;TOPICAL - 0.1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 1 Pharm-RX Chemical, 8 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 11 Actylis, 13 BASF, 1 CD Formulation, 3 Clariant, 7 Corel Pharma Chem, 1 Esteem Industries, 2 Finar, 5 Gangwal Chemicals, 1 Gloria Interchem, 7 Lubrizol Life Science Health, 1 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Pluviaendo, 8 Seppic, 1 Valens Pharmachem

2 EUROAPI
1 Rochem International Inc
1 Pharm-RX Chemical
8 Nanjing Well Pharmaceutical
2 Kirsch Pharma
11 Actylis
13 BASF
1 CD Formulation
3 Clariant
7 Corel Pharma Chem
1 Esteem Industries
2 Finar
5 Gangwal Chemicals
1 Gloria Interchem
7 Lubrizol Life Science Health
1 Microlex e.U
2 Nanjing Bold Chemical
2 Nomisma Healthcare
1 Pluviaendo
8 Seppic
1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Topical, 25 Solubilizers, 19 Thickeners and Stabilizers, 17 Parenteral, 11 Controlled & Modified Release, 8 Emulsifying Agents, 8 Film Formers & Plasticizers, 7 Surfactant & Foaming Agents, 5 Rheology Modifiers, 4 Granulation, 3 Coating Systems & Additives, 3 Direct Compression, 2 Lubricants & Glidants, 2 Fillers, Diluents & Binders, 2 API Stability Enhancers, 1 Co-Processed Excipients

36 Topical
25 Solubilizers
19 Thickeners and Stabilizers
17 Parenteral
11 Controlled & Modified Release
8 Emulsifying Agents
8 Film Formers & Plasticizers
7 Surfactant & Foaming Agents
5 Rheology Modifiers
4 Granulation
3 Coating Systems & Additives
3 Direct Compression
2 Lubricants & Glidants
2 Fillers, Diluents & Binders
2 API Stability Enhancers
1 Co-Processed Excipients

DIGITAL CONTENT

30 News #PharmaBuzz

30 News #PharmaBuzz

GLOBAL SALES INFORMATION

22 US Medicaid Prescriptions, 10 Regulatory FDF Prices

22 US Medicaid Prescriptions
10 Regulatory FDF Prices

MARKET PLACE

30 APIs, 3 FDF Dossiers

30 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 3 Health Canada Patents

6 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 11 Others

3 EDQM
11 Others

$ API Ref.Price (USD/KG) : 9,226 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6GALDERMA LABS LP

filter Patent Number Reset all filters

6 All

01 17998467

02 18071644

03 18080537

04 18129362

05 18435502

06 18709392

API Patent Reset all filters

6 All

01 6Blank

filter FDF Patent Reset all filters

6 All

01 4Y

02 2Blank

filter Expiration Date Reset all filters

6 All

01 22026-09-15

02 32027-07-18

03 12028-05-31

Product Main Page

01

GALDERMA LABS LP

ADAPALENE; BENZOYL PEROXIDE

ASCO GU

Not Confirmed

GALDERMA LABS LP

ASCO GU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-18

ADAPALENE; BENZOYL PEROXIDE

US Patent Number : 8080537

Drug Substance Claim :

Drug Product Claim :

Application Number : 22320

Patent Use Code : U-1078

Delist Requested :

Patent Use Description : TREATMENT OF ACNE

Patent Expiration Date : 2027-07-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GALDERMA LABS LP

ADAPALENE; BENZOYL PEROXIDE

ASCO GU

Not Confirmed

GALDERMA LABS LP

ASCO GU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-18

ADAPALENE; BENZOYL PEROXIDE

US Patent Number : 8129362

Drug Substance Claim :

Drug Product Claim :

Application Number : 22320

Patent Use Code : U-1078

Delist Requested :

Patent Use Description : TREATMENT OF ACNE

Patent Expiration Date : 2027-07-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GALDERMA LABS LP

ASCO GU

Not Confirmed

GALDERMA LABS LP

ASCO GU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-05-31

US Patent Number : 7998467

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22502

Patent Use Code : U-1078

Delist Requested :

Patent Use Description : TREATMENT OF ACNE

Patent Expiration Date : 2028-05-31

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GALDERMA LABS LP

ASCO GU

Not Confirmed

GALDERMA LABS LP

ASCO GU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-09-15

US Patent Number : 8435502

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22502

Patent Use Code : U-1078

Delist Requested :

Patent Use Description : TREATMENT OF ACNE

Patent Expiration Date : 2026-09-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GALDERMA LABS LP

ADAPALENE; BENZOYL PEROXIDE

ASCO GU

Not Confirmed

GALDERMA LABS LP

ASCO GU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-18

ADAPALENE; BENZOYL PEROXIDE

US Patent Number : 8071644

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22320

Patent Use Code : U-1078

Delist Requested :

Patent Use Description : TREATMENT OF ACNE

Patent Expiration Date : 2027-07-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

GALDERMA LABS LP

ASCO GU

Not Confirmed

GALDERMA LABS LP

ASCO GU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-09-15

US Patent Number : 8709392

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22502

Patent Use Code : U-1078

Delist Requested :

Patent Use Description : TREATMENT OF ACNE

Patent Expiration Date : 2026-09-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.